Skip to main content
. Author manuscript; available in PMC: 2008 Jun 20.
Published in final edited form as: J Acoust Soc Am. 2008 Mar;123(3):1522–1543. doi: 10.1121/1.2836786

TABLE I.

Subject information. Gender, age when tested, etiology of deafness, duration of bilateral severe-to-profound hearing loss prior to implantation, duration of implant use prior to the study, implanted device with electrode type (SPRL=spiral; HF=HiFocus; HFP=HiFocus with positioner) for Clarion users only, and insertion depth.

Subject M/F Age Etiology Duration (years) Cl Use (years) Device (electrode type) Depth (mm)
C03 F 53.4 Progressive, familial 27 4.2 C-I (SPRL) 25
C05 M 47.8 Unknown, sudden <1 5.6 C-I (SPRL) 25
C16 F 50.1 Progressive 13 2.6 C-I (HF) 25
C18 M 71.4 Otosclerosis 33 4.6 C-I (HFP) 25
C23 F 42.7 Progressive 27 1.1 C-I (HFP) 25
D08 F 54.7 Otosclerosis 13 3.8 C-II (HF) 25
N09 M 67.4 Meniere’s disease 1 10.6 N22 22
N13 M 65.2 Progressive, familial 4 12.8 N22 24
N14 M 58.0 Progressive 1 8.4 N22 25
N28 M 65.6 Meningitis <1 8.6 N22 25
N32 M 37.2 Maternal rubella <1 7.4 N22 23
N34 F 57.9 Mumps, progressive 9 4.4 N22 22